{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-034103","form_type":"8-K","ticker":"QUCY","cik":"0001874252","company_name":"Quantum Cyber N.V.","filed_at":"2026-03-25T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.642896+00:00","generated_at":"2026-05-15T09:04:29.273635+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Mainz Biomed receives Nasdaq minimum bid price deficiency notice; 180-day cure period until Sep 16, 2026","bullets":["Nasdaq notified Mainz Biomed on Mar 20, 2026 that its share price closed below $1.00 for 30 consecutive business days through Mar 19, 2026.","Company has 180 calendar days, until Sep 16, 2026, to regain compliance by maintaining a closing bid price of at least $1.00 for 10 consecutive business days.","If not cured by Sep 16, 2026, Mainz may be eligible for an additional 180-day period if it meets other listing standards and notifies Nasdaq of intent to cure via reverse stock split.","There can be no assurance of regaining compliance or avoiding delisting; the letter has no immediate impact on trading."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-034103","json":"https://secwatch.observer/filing/0001213900-26-034103.json","markdown":"https://secwatch.observer/filing/0001213900-26-034103.md","text":"https://secwatch.observer/filing/0001213900-26-034103.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1874252/000121390026034103/0001213900-26-034103-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1874252/000121390026034103/ea0283153-8k_mainz.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T09:04:29.273635+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"d77e08c634fb7265dbaf74c0705a4bbb8e55c82e","claim":"Quantum Cyber N.V. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).","evidence_excerpt":"March 20, 2026, Mainz Biomed N.V. (the “ Company ”) received a letter from the Listing Qualifications Department of the Nasdaq Stock Market indicating that, based upon the closing bid price of the Company’s ordinary shares, nominal value €0.01 per share (the “ Ordinary Shares ”) for the 30 consecutive business days between February 5, 2026, to March 19, 2026, the Company did not meet the minimum bid price of $1.00 per share required for continued listing on The Nasdaq Capital Market (“ Nasdaq ”) pursuant to Nasdaq Listing Rule 5550(a)(2). The letter also indicated that the Company will be prov","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1874252/000121390026034103/0001213900-26-034103-index.htm","confidence":0.98,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"deficiency notice"},{"label":"Deficiency","value":"minimum bid price"},{"label":"Rules","value":"5550(a)(2), 5810(c)(3)(A)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}